Tempus AI (NASDAQ:TEM) Stock Rating Lowered by Stifel Nicolaus

Tempus AI (NASDAQ:TEM) was downgraded by Stifel Nicolaus from a “buy” rating to a “hold” rating in a report issued on Monday, MarketBeat.com reports. They currently have a $65.00 price objective on the stock, up from their previous price objective of $45.00. Stifel Nicolaus’ price target would suggest a potential downside of 4.47% from the company’s previous close.

A number of other analysts have also weighed in on TEM. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Needham & Company LLC reissued a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Piper Sandler initiated coverage on Tempus AI in a report on Monday, August 12th. They set a “neutral” rating and a $40.00 price target for the company. Finally, Loop Capital increased their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $54.22.

Tempus AI Trading Down 12.3 %

Tempus AI stock opened at $68.04 on Monday. The business’s 50 day simple moving average is $50.90. The company has a current ratio of 2.69, a quick ratio of 3.52 and a debt-to-equity ratio of 8.17. Tempus AI has a 52-week low of $22.89 and a 52-week high of $79.49.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of TEM. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI in the 3rd quarter valued at approximately $30,000. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Tempus AI by 1,591.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the period. GSA Capital Partners LLP acquired a new position in Tempus AI in the 3rd quarter valued at $306,000. Sigma Planning Corp purchased a new position in Tempus AI during the 3rd quarter worth $1,323,000. Finally, ARK Investment Management LLC lifted its stake in shares of Tempus AI by 355.0% in the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after acquiring an additional 1,855,459 shares during the period.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.